Stethoscope and laptop

Save Sight Registries

Leading the way in fighting the incidence of blindness globally
We provide a scientific, web-based platform for eye specialists worldwide to capture high-quality clinical data on patient treatments and outcomes from routine clinical practice.

About us

The first of its kind in the world, our registries hold 15 years of data on ophthalmic treatment outcomes for neovascular (wet) age-related macular degeneration (wet AMD).

Our system tracks and analyses "real world" patient treatment outcomes for some of the leading causes of visual impairment, including neovascular age-related macular degeneration (“wet” AMD), atrophy, choroidal neovascularisation, diabetic retinopathy, retinal vein occlusion, glaucoma, keratoconus, dry eye, uveitis, inherited retinal diseases, uveal melanoma, and retinopathy of prematurity. The Registries are an international project, and has collected data from Europe, Asia, Africa and North America.

The Save Sight Registries consist of seven registries:

Our registries are immediately relevant to clinicians, researchers, public health providers and policy makers seeking to fight ocular blindness and improve patient outcomes in Australia and internationally.

The Registries' standardised dataset is compliant with international measurement tools for health outcomes (ICHOM) for our neovascular age-related macular degeneration module and enables current and emerging therapies to be evaluated for clinical efficacy, cost-effectiveness and safety.

Save Sight Registry Team

Save Sight Registries Team Photo

Left to right: Mia Rainey, Robert Medynski, Alison Grinyer, Professor Mark Gillies, Dianna Raad, Marco Garcia Molina, Mila Kolmogorova..

Save Sight Registries

  • South Block, Sydney Eye Hospital 8 Macquarie Street Sydney NSW 2000

Professor Mark Gillies

Mark Gillies headshot
Chief investigator
View academic profile